P13: CAN PATIENT-REPORTED OCULAR SYMPTOMS GUIDE DOSE MODIFICATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING BELANTAMAB MAFODOTIN?

ABSTRACT:

SUBMITTER: Popat R 

PROVIDER: S-EPMC9009801 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature